Review article: Skin complications associated with inflammatory bowel disease

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 20, Issue 4, 2004, Pages 50-53

  Tavarela Veloso, F ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS; THALIDOMIDE;

ACRODERMATITIS ENTEROPATHICA; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ANUS FISTULA; APHERESIS; AUTOIMMUNE DISEASE; CLINICAL TRIAL; CROHN DISEASE; CYTAPHERESIS; DISEASE COURSE; ENTERITIS; ERYTHEMA NODOSUM; GRANULOCYTAPHERESIS; GRANULOMATOUS SKIN DISEASE; HIGH RISK POPULATION; HISTOLOGY; HUMAN; INCIDENCE; INFLAMMATION; MAINTENANCE THERAPY; METASTATIC CROHN DISEASE; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PSORIASIS; PYODERMA GANGRENOSUM; RECURRENT DISEASE; REVIEW; SKIN DEFECT; SKIN MANIFESTATION; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; NUTRITION DISORDERS; SKIN DISEASES;

EID: 4844222815     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Greenstein AJ, Janowiz HD, Sachar PB. The extra-intestinal complications of Crohn's disease and ulcerative colitis. A study of 700 patients. Medicine 1976; 55: 401-12.
2. Tavarela Veloso F, Carvalho S, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996; 23: 29-34.
3. Lebwohl M, Lebwohl D. Cutaneous manifestations of inflammatory bowel disease. Inflamm Bowel Dis 1998; 4: 142-8.
4. Tavarela Veloso F, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 2001; 7: 306-13.
5. Borley N, Mortenses N, Jewell D. MRI scanning in perianal Crohn's disease: an important diagnostic adjunct. Inflamm Bowel Dis 1999; 5: 231-3.
6. Tavarela Veloso F, Cardoso V, Fraga J, et al. Spontaneous umbilical fistula in Crohn's disease. J Clin Gastroenterol 1989; 11: 197-200.
7. Sheldon DG, Sawchuck L, Kozarek K, Thirlby R. Twenty cases of peristomal pyoderma gangrenosum. Diagnostic implications and clinical management. Arch Surg 2000; 135: 564-9.
8. Sandborn WJ, Fazio VW, Feagan BG, et al. AGA technical review on perianal Crohn's disease. Gastroenterology 2003; 125:1508-30.
9. Guest GD, Fink RL. Metastatic Crohn's disease: a case report of an unusual variant and review of the literature. Dis Colon Rectum 2000; 43: 1764-6.
10. Kafity AA, Pellegrini AE, Fronkes JJ. Metastatic Crohn's disease. A rare cutaneous manifestation. J Clin Gastroenterol 1993; 17: 300-3.
11. Van Dullemen H, de Jong E, Slors F, et al. Treatment of therapy-resistant perianal metastatic Crohn's disease after protectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2: report of two cases. Dis Colon Rectum 1998; 41: 98-102.
12. Mahadeven V, Sandborn W. Infliximab for the treatment of oral Crohn's disease. Inflamm Bowel Dis 2001; 7: 38-42.
13. Rankin GB, Watts HD, Melnyl CJ, Kelley ML. National Cooperative Crohn's Disease Study: extra-intestinal manifestations and perianal complications. Gastroenterology 1979; 77: 914-20.
14. Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol 1985; 80: 615-20.
15. Lichtman SN, Sartor RB. Extraintestinal manifestations of inflammatory bowel diseases: clinical aspects and natural history. In: Targan SR, Shanahan F. eds. Inflammatory Bowel Disease. From Bench to Bedside, Baltimore, MD: Williams & Wilkins, 1994: 317-31.
16. Veloso T, Halstensen TS. Complement deposits in inflammatory bowel disease [letter]. Gastroenterology 1990; 99: 1541-2.
17. Fleisher M, Rubin S, Levine A, et al. Infliximab in the treatment of steroid refractory erythema nodosum of IBD. Gastroenterology 2002; 122(Suppl. 1): A618(Abstract).
18. Bennett ML, Jackson JM, Jorizzo JL, et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine 2000; 79: 37-46.
19. Wollina V. Clinical management of pyoderma gangrenosum. Am J Clin Dermatol 2002; 3: 14-58.
20. D'Inca R, Fagiuoli SC. Tacrolimus to treat pyoderma gangrenosum resistant to cyclosporine. Ann Intern Med 1998; 128: 783-4.
21. Hohenleutner U, Mohr VD, Michel S, Landthaler M. Mycophenolate mofetil and cyclosporine treatment for recalcitrant pyoderma gangrenosum. Lancet 1997; 350: 1748.
22. Friedman S, Marison J, Scherl E, et al. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflamm Bowel Dis 2001; 7: 1-7.
23. Hong JJ, Merel NH, Hanauer SB. Treatment of pyoderma gangrenosum complicating Crohn's disease with infliximab. Gastroenterology 2001; 120(Suppl. 1): A621(Abstract).
24. Ohmori T, Yamagiwa A, Nakamura I, Nishikawa K, Saniabadi AR. Treatment of pyoderma gangrenosum associated with Crohn's disease. Am J Gastroenterol 2003; 98: 2001-2.
25. Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 2003; 98: 1824-6.
26. Kemmett D, Hunter JA. Sweet's syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol 1990; 23: 503-7.
27. Ochsendorf FR. Cutaneous manifestations of IBD and IBD-associated inflammatory lesions. In: Lembcke B, Kruis W, Sartor RB, eds. Systemic Manifestations of IBD. Lancaster: Kluwer, 1998: 67-93.
28. Lee FI, Bellary SV, Francis C. Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 1990; 85: 962-3.
29. Chugh S, Dilawari JB, Sawhney IMS, et al. Polymyositis associated with ulcerative colitis. Gut 1993; 34: 567-9.
30. Hoffmann RM, Kruis W. Rare extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 140-7.